Humana Inc. $HUM Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB cut its holdings in shares of Humana Inc. (NYSE:HUM) by 73.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,321 shares of the insurance provider’s stock after selling 9,256 shares during the quarter. Handelsbanken Fonder AB’s holdings in Humana were worth $1,319,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in Humana by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after buying an additional 106,030 shares during the period. Capital International Investors lifted its holdings in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares during the period. Pzena Investment Management LLC boosted its position in shares of Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after acquiring an additional 1,398,774 shares during the last quarter. State Street Corp boosted its position in shares of Humana by 1.8% in the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after acquiring an additional 97,211 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in Humana by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 3,184,569 shares of the insurance provider’s stock valued at $812,540,000 after purchasing an additional 23,732 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Royal Bank Of Canada increased their price target on shares of Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 9th. Needham & Company LLC started coverage on Humana in a report on Wednesday, May 20th. They set a “buy” rating for the company. Seaport Research Partners lowered Humana to a “neutral” rating in a research report on Wednesday, May 20th. Mizuho lifted their target price on Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Finally, Piper Sandler raised Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target for the company in a research report on Thursday, July 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $395.22.

Humana Stock Down 0.6%

Shares of Humana stock opened at $382.13 on Wednesday. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The stock has a market cap of $45.89 billion, a price-to-earnings ratio of 36.15, a price-to-earnings-growth ratio of 2.23 and a beta of 0.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a fifty day moving average price of $382.93 and a 200 day moving average price of $278.32.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter last year, the company earned $6.27 earnings per share. Humana’s revenue for the quarter was up 26.2% on a year-over-year basis. Equities research analysts forecast that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.